Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
Cancer Genetics and Cytogenetics
|
July 5, 2005
Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells
V Koneti Rao, Darawalee Wangsa, Robert W Robey, et al.
Biochemical Pharmacology
|
February 1, 2008
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))
Robert W Robey, Suneet Shukla, Elizabeth M Finley, et al.
Translational Oncology
|
October 31, 2020
Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
Ruchi P Patel, Skyler Kuhn, Da Yin, et al.
Molecular Cancer Therapeutics
|
December 20, 2007
New inhibitors of ABCG2 identified by high-throughput screening
Curtis J Henrich, Robert W Robey, Heidi R Bokesch, et al.
Biochemistry
|
July 21, 2004
Mutational analysis of ABCG2: role of the GXXXG motif
Orsolya Polgar, Robert W Robey, Kuniaki Morisaki, et al.
Cancer Research
|
September 17, 2005
ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates
Assaf Shafran, Ilan Ifergan, Eran Bram, et al.
Expert Review of Anticancer Therapy
|
July 22, 2010
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Cliona Grant, Fahd Rahman, Richard Piekarz, et al.
Experimental Cell Research
|
December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models
Andrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Journal of Biomolecular Screening
|
February 24, 2006
A high-throughput cell-based assay for inhibitors of ABCG2 activity
Curtis J Henrich, Heidi R Bokesch, Michael Dean, et al.
Experimental Cell Research
|
January 24, 2020
A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer
James P Madigan, Robert W Robey, Joanna E Poprawski, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
Cancer Genetics and Cytogenetics
|
July 5, 2005
Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells
V Koneti Rao, Darawalee Wangsa, Robert W Robey, et al.
Biochemical Pharmacology
|
February 1, 2008
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))
Robert W Robey, Suneet Shukla, Elizabeth M Finley, et al.
Translational Oncology
|
October 31, 2020
Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
Ruchi P Patel, Skyler Kuhn, Da Yin, et al.
Molecular Cancer Therapeutics
|
December 20, 2007
New inhibitors of ABCG2 identified by high-throughput screening
Curtis J Henrich, Robert W Robey, Heidi R Bokesch, et al.
Biochemistry
|
July 21, 2004
Mutational analysis of ABCG2: role of the GXXXG motif
Orsolya Polgar, Robert W Robey, Kuniaki Morisaki, et al.
Cancer Research
|
September 17, 2005
ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates
Assaf Shafran, Ilan Ifergan, Eran Bram, et al.
Expert Review of Anticancer Therapy
|
July 22, 2010
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Cliona Grant, Fahd Rahman, Richard Piekarz, et al.
Experimental Cell Research
|
December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models
Andrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Journal of Biomolecular Screening
|
February 24, 2006
A high-throughput cell-based assay for inhibitors of ABCG2 activity
Curtis J Henrich, Heidi R Bokesch, Michael Dean, et al.
Experimental Cell Research
|
January 24, 2020
A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer
James P Madigan, Robert W Robey, Joanna E Poprawski, et al.
Page
of 13